Page last updated: 2024-09-04

canertinib and Arachnoidal Cerebellar Sarcoma, Circumscribed

canertinib has been researched along with Arachnoidal Cerebellar Sarcoma, Circumscribed in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Bont, ES; den Dunnen, WF; Diks, SH; Hoving, EW; Lourens, HJ; Meeuwsen-de Boer, T; Plasschaert, SL; Zomerman, WW	1

Other Studies

1 other study(ies) available for canertinib and Arachnoidal Cerebellar Sarcoma, Circumscribed

Article	Year
Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines. PloS one, 2015, Volume: 10, Issue:10 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Crizotinib; Drug Resistance, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Hepatocyte Growth Factor; Humans; Medulloblastoma; Morpholines; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Signal Transduction	2015

Article

Year

Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines.

PloS one, 2015, Volume: 10, Issue:10

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Crizotinib; Drug Resistance, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Hepatocyte Growth Factor; Humans; Medulloblastoma; Morpholines; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Signal Transduction

2015